AI-developed drug will be in trials by year-end, says Google’s Hassabis
Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas
Read more at Financial Times
-
GDC survey reveals a rocky year of layoffs and AI skepticism for game developers
The 2025 GDC survey revealed the impact of industry-wide layoffs in 2024 where one of every 11 game developers lost a job.VentureBeat - 11h -
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summers says
Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of years thanks to technology, former U.S. Treasury Secretary Larry Summers ...CNBC - 12h -
Speedier drug trials and better films: how AI is transforming businesses
From aviation to retail, many industries are already looking to artificial intelligence to improve productivity. Keir Starmer this week announced a 50-point plan that aims to give the UK world ...The Guardian - 4d -
TikTok and Google CEOs to attend Trump inauguration, sources say
The news comes as a law banning TikTok, which is owned by Chinese firm ByteDance, is set to go into effect on Jan. 19.CBS News - 5d -
Hallucinations in AI: How GSK is addressing a critical problem in drug development
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.VentureBeat - Jan. 14 -
Google Joins the AI Shopping Revolution With Agent Tools for Retailers
The next stage of AI development, which lets the technology act with more autonomy and performs some customer service actions, is being applied to an industry that must constantly embrace change.Inc. - Jan. 13 -
GSK nears $1bn deal for biotech developing drug for rare tumour
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in USFinancial Times - Jan. 8 -
Labor Board Says Google Should Have to Bargain With Contractors’ Union
A National Labor Relations Board complaint says that as a joint employer of workers from IT staffing firm Accenture Flex, the tech giant should be obliged to negotiate with its union.Inc. - Jan. 7 -
Google maps the future of AI agents: Five lessons for businesses
Google's groundbreaking white paper reveals how AI agents leverage advanced reasoning, real-time data access and autonomous decision-making.VentureBeat - Jan. 6
More from Financial Times
-
SoftBank and OpenAI back sweeping AI infrastructure project in US
Donald Trump calls $100bn initiative a ‘declaration of confidence in America’Financial Times - 35m -
Trump latest: Trump says he is considering 10% tariff on China
Financial Times - 5h -
Trump threatens to double tax rates for foreign nationals and companies
President orders officials to draw up retaliatory measures against ‘extraterritorial’ taxesFinancial Times - 10h -
Five takeaways on Trump’s opening trade salvo
President vows to correct ‘unfair practices’ as US trading partners prepare for an era of tariffsFinancial Times - 8h -
‘Will President Trump even notice Europe?’ asks Zelenskyy
Ukraine’s president delivers scathing critique in Davos of continent’s reluctance to spend more on defenceFinancial Times - 11h
More in Business
-
Trump pardons Silk Road creator Ross Ulbricht
President Trump grants full pardon to Silk Road founder Ross Ulbricht, early bitcoin advocate.CNBC - 18m -
SoftBank and OpenAI back sweeping AI infrastructure project in US
Donald Trump calls $100bn initiative a ‘declaration of confidence in America’Financial Times - 35m -
2 Families, in Business 50 Years, Fight for Control of Korea Zinc
Control of Korea Zinc, the world’s largest producer of zinc, is at stake in a battle challenging the country’s entrenched chaebol system of powerful conglomerates.The New York Times - 55m -
Trump says he's considering a 10% tariff on China beginning as soon as Feb. 1
On Tuesday, President Donald Trump floated a 10% duty on China, with an expected start date of Feb. 1.CNBC - 2h -
Tesla’s ‘Trump bump’ fades as stock falls alongside rest of EV sector
Investors still expect Musk to benefit more broadly from Trump 2.0.MarketWatch - 2h